Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension
Titel:
Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension
Auteur:
Kim, Ho Jin Nakashima, Ichiro Viswanathan, Shanthi Wang, Kai-Chen Shang, Shulian Miller, Larisa Yountz, Marcus Wingerchuk, Dean M. Pittock, Sean J. Levy, Michael Berthele, Achim Totolyan, Natalia Palace, Jacqueline Barnett, Michael H. Fujihara, Kazuo